Downloads provided by UsageCounts
handle: 10044/1/70088
Alcoholic hepatitis (AH) is a life-threatening condition characterized by profound hepatocellular dysfunction for which targeted treatments are urgently needed. Identification of molecular drivers is hampered by the lack of suitable animal models. By performing RNA sequencing in livers from patients with different phenotypes of alcohol-related liver disease (ALD), we show that the development of AH is characterized by the defective activity of liver-enriched transcription factors (LETFs). TGFb1is a key upstream transcriptome regulator in AH and induces the use of HNF4aP2 promoter in hepatocytes, which results in defective metabolic and synthetic functions. Gene polymorphisms in LETFs including HNF4aare not associated with the development of AH. In contrast, epigenetic studies show that AH livers have profound changes in DNA methylation state and chromatin remodeling, affecting HNF4a-dependent gene expression. We conclude that targeting TGFb1and epigenetic drivers that modulate HNF4a-dependent gene expression could be beneficial to improve hepatocellular function in patients with AH.
{"references": ["Argemi J., Latasa M.U., Atkinson S.R., Blokhin I.O., Massey V., Gue J.P., Cabezas J., Lozano J.J., Van Booven D., Bell A., Cao S., Vernetti L.A., Arab J.P., Ventura-Cots M., Edmunds L.R., Fondevilla C., St\u00e4rkel P., Dubuquoy L., Louvet A., Odena G., Gomez J.L., Aragon T., Altamirano J., Caballeria J., Jurzak14, Taylor, D. L., Berasain C., Wahlestedt C., Monga S.P., Morgan MY, Sancho-Bru P., Mathurin P., Furuya S., Lackner C., Rusyn I., Shah V.H.,Thursz M.R., Mann J., Avila M.A., Bataller R. \"Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis\". Nat Commun. 2019, Accepted"]}
Data used in figures 8 and 10 of the mentioned manuscript is included in these datasets. These datasets include 7 GWAS summary files, described in GWAS Summary_metadata.txt file and 1 ChIP-seq peak calling result file, which variables are described in NatCommun_PeakCalling_results_metadata.txt file. Raw data of GWAS is available upon request to Dr. Mark Thursz (Imperial College, London UK, m.thursz@imperial.ac.uk). Raw data of ChIP-seq is available upon request to Dr. Vijay Shah (Mayo Clinic, Rochester, MN, USA, vshah@mayo.edu).
ChIP-seq, 570, Alcoholic Hepatitis, TGFB1, 610, GWAS, Alcohol-related Liver Disease, HNF4A
ChIP-seq, 570, Alcoholic Hepatitis, TGFB1, 610, GWAS, Alcohol-related Liver Disease, HNF4A
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 11 | |
| downloads | 12 |

Views provided by UsageCounts
Downloads provided by UsageCounts